INDIANAPOLIS, Jan. 14, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced plans to add two more cost-saving options to its suite of solutions for people who use Lilly insulin by ...

Eli Lilly & Company LLY announced plans to launch lower-priced versions of two of its insulin product, Humalog – Humalog Mix75/25 KwikPen and Humalog Junior KwikPen. The list price of these low-priced ...

INDIANAPOLIS, May 27, 2015 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Humalog ® 200 units/mL KwikPen ® (insulin lispro 200 units/mL; U-200), a pre-filled pen containing a ...

The U.S. Food and Drug Administration (FDA) has approved Humalog ® 200 units/mL KwikPen ® (insulin lispro 200 units/mL; U-200), a pre-filled pen containing a concentrated formulation of Lilly's ...

Humalog Junior KwikPen U-100 will be available as 5-count cartons. The BD pen needles are recommended for use with Humalog Junior KwiKPen. The Humalog Junior KwikPen (insulin lispro; Eli Lilly), a ...

Lilly has expanded its insulin affordability options for people with diabetes available through the Lilly Diabetes Solution Center. The Lilly Insulin Value Program allows anyone with commercial ...

The Food and Drug Administration (FDA) has approved Humalog 200 units/mL KwikPen (insulin lispro 200 units/mL [U-200]; Eli Lilly) to improve glycemic control in patients with type 1 and type 2 ...

Please provide your email address to receive an email when new articles are posted on . The FDA recently approved a 200 units/mL Humalog KwikPen, a pre-filled, rapid-acting insulin pen designed to ...

INDIANAPOLIS, Ind.– Indianapolis-based Eli Lilly and Company announced plans Tuesday to offer two of its insulin pens for half the cost of the branded versions. The two pens will be lower-priced ...

Please provide your email address to receive an email when new articles are posted on . The Humalog Junior KwikPen, a prefilled, rapid-acting insulin pen designed to improve glycemic control in people ...

When Erin Gilmer filled her insulin prescription at a Denver-area Walgreens in January, she paid $8.50. U.S. taxpayers paid another $280.51. "It eats at me to know that taxpayer money is being wasted, ...

Marks approval of first concentrated mealtime insulin analog in the U.S. and expands Lilly's portfolio of medicines for people with type 1 and type 2 diabetes INDIANAPOLIS, May 27, 2015 /PRNewswire/ - ...